Dr. Reddy's Laboratories Cash Flow - Annual (NYSE:RDY)

Add to My Stocks
$35.06 $2.04 (6.18%) RDY stock closing price Jun 15, 2018 (Closing)

For analyzing any company like Dr. Reddy's Laboratories from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Dr. Reddy's Laboratories profits and Dr. Reddy's Laboratories debt. Dr. Reddy's Laboratories had cash and cash equivalents of $76M at beginning of the year and $59M at year end for 2017. Dr. Reddy's Laboratories cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Dr. Reddy's Laboratories had an inflow of $332M from operating activities, $-57M spend due to financing activities, and $-285M outflow due to investing activities for 2017.

View details of Dr. Reddy's Laboratories cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Apr - Mar201720162015201420132012201120102009
Net Income Cash Flow
186M302M356M359M308M280M248M24M-102M
Depreciation Depletion Amortization Cash-Flow174M155M130M118M102M102M93M93M75M
Net Increase (Decrease) in Assets Liabilities-83M-3M-241M-172M-343M-264M-151M-96M-216M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net54M168M156M19M177M199M-10M277M333M
Net Cash from (used by) Operating Activities
332M623M402M324M244M317M180M294M90M
Increase (Decrease) in Prop Plant And Equipment-188M-180M-147M-167M-121M-134M-196M-91M-87M
Acquisition Disposition of Subsidiaires--120M-4M--32M--26M--63M
Increase (Decrease) in Investments337M16M-133M-118M-110M-208M82M-67M86M
Other Cash Inflow (Outflow) from Investment Activities-433M-24M-83M8M9M-25M-54M2M-5M
Net Cash from (used by) Investment Activities
-285M-308M-368M-277M-254M-367M-194M-156M-69M
Issuance (Purchase) of Equity Shares-242M-3M---1M--
Issuance (Repayment) of Debt Securities-80M-177M-60M154M-211M-87M-79M-38M
Increase (Decrease) in Bank & Other Borrowings332M-4M65M-3M43M-72M281M-25M
Payment of Dividends & Other Cash Distributions-52M-62M-58M-50M-50M-44M-69M-27M-15M
Other Cash from (used by) Financing Activities-14M-14M-17M-105M-25M-22M-134M-12M-22M
Net Cash from (used by) Financing Activities
-57M-257M-66M-4M-32M73M-8M-118M-50M
Effect of Exchange Rate Changes on Cash-8M-65M-17M13M2M10M3M5M-2M
Net Change in Cash & Cash Equivalents
-17M-7M-49M57M-42M34M-20M26M-31M
Cash & Equivalents at Beginning of Year76M81M136M84M135M111M147M120M137M
Cash & Equivalents at Year End59M74M87M141M93M145M127M146M106M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Dr. Reddy's Laboratories stock comparison chart provides an easy way to compare the stock price with peers along with details of Dr. Reddy's Laboratories stock price history.
The statement of cash flows can be categorized into three main sections:

  • Dr. Reddy's Laboratories had a Net Change in Cash and Cash Equivalents of $-17M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Dr. Reddy's Laboratories stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Dr. Reddy's Laboratories gained $332M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-285M for RDY stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-57M for Dr. Reddy's Laboratories.

Key Financial Ratios For Dr. Reddy's Laboratories Cash Flow

FCF margin
0

Annual Cash Flow Statements For Dr.Reddy's Laboratories Ltd (ADR) Peers

ASPEN PHARMACR cash flow, Mylan cash flow, Novartis cash flow, Sanofi cash flow, Teva Pharmaceutical cash flow